Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03302273 · ClinicalTrials.gov registry record · NA
Corneal Epithelial Stem Cells and Dry Eye Disease
A NA study of Dry Eye and Dry Eye Syndromes, sponsored by Sloan W. Rush, MD.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT03302273: Completed NA study of Dry Eye and Dry Eye Syndromes, sponsored by Sloan W. Rush, MD.
NCT03302273 is a NA study of Dry Eye and Dry Eye Syndromes that has completed, run by Sloan W. Rush, MD. The registered enrollment target is 17 participants, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03302273, a NA study of Dry Eye and Dry Eye Syndromes, has completed, sponsored by Sloan W. Rush, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
To study of a novel, therapeutic Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT/P) in the treatment of severe dry eye disease that is failing conventional treatments. This pilot study will carefully observe and monitor each qualifying and willing individual for response to treatment, signs of toxicity and adverse effects from the treatment, and for ability of the treatment to improve comfort and restore vision.
Primary Outcome
Patient Reported Outcome by Survey
Conditions Studied
Interventions
- OTHER Corneal Epithelial Stem Cell Transplant
Study Locations (1)
Texas
- Rush Eye Associates - Amarillo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2022-04-01 |
| Phase | NA |
What the finished NCT03302273 record still lists
NCT03302273 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (82% lower).
The record links to 6 conditions, with Dry Eye appearing as the primary indexed condition, and to 1 intervention - of which Corneal Epithelial Stem Cell Transplant is the first listed.
NCT03302273 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03302273 about?
NCT03302273 is a clinical study titled "Corneal Epithelial Stem Cells and Dry Eye Disease". To study of a novel, therapeutic Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT/P) in the treatment of severe dry eye disease that is failing conventional treatments. This pilot study will carefully observe and monitor each qualifying and willing individual for response to treatmen...
What is the current status of trial NCT03302273?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2019-02-01. Estimated completion is 2022-04-01.
What conditions does trial NCT03302273 study?
This clinical trial studies the following conditions: Dry Eye, Dry Eye Syndromes, Blepharitis, Ocular Inflammation, Ocular Surface Disease.
What interventions are being tested in trial NCT03302273?
The interventions under investigation include: Corneal Epithelial Stem Cell Transplant (OTHER).
Who is sponsoring clinical trial NCT03302273?
This trial is sponsored by Sloan W. Rush, MD, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03302273 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03302273's enrollment target sits among peer trials
17 40th of 41 higher than 1 of 41 other Dry Eye trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dry Eye trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The THINK Study Incidence of Neurotrophic Keratopathy)
RECRUITING · NA
-
Low Level Light Therapy & Skin Pigmentation
RECRUITING · NA
-
Acute Comfort of Lubricant Eye Drops FID 112903
COMPLETED · NA
-
Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion
COMPLETED · NA
-
Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea
COMPLETED · NA
-
Intense Pulse Light Treatment With Meibomian Gland Expression of the Upper Eyelids in Dry Eye Disease
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI